Remicade [infliximab] Treatment Registry in Rheumatoid Arthritis I.

Trial Profile

Remicade [infliximab] Treatment Registry in Rheumatoid Arthritis I.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2013

At a glance

  • Drugs Infliximab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Schering-Plough
  • Most Recent Events

    • 24 Feb 2010 Actual patient number (33) added as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top